baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

INCYTE DL-,001/ US45337C1027 /

06/06/2024 08:01:46	Chg. +0.26	Volume	Bid16:55:15	Ask16:55:15	Market Capitalization	Dividend Y.	P/E Ratio
54.08EUR	+0.48%	0 Turnover: 0.00	54.08Bid Size: 500	54.16Ask Size: 500	12.17 bill.EUR	-	-

GlobeNewswire 29/05 Lynch Carpenter Investigates Claims in Cencora, Inc. Data Breach

GlobeNewswire 28/05 Keros Therapeutics Appoints Jean-Jacques Bienaimé to its Board of Directors

GlobeNewswire 09/05 MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim ...

GlobeNewswire 08/05 Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update

GlobeNewswire 30/04 Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer

GlobeNewswire 02/04 HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sin...

GlobeNewswire 01/04 CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast ...

GlobeNewswire 28/02 Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Up...

GlobeNewswire 09/01 Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030

TeleTrader 12/12/2023 Wall Street closes higher after inflation report

GlobeNewswire 09/12/2023 CURE Media Group announces winners of the 2023 MPN Heroes® Recognition Program

GlobeNewswire 16/11/2023 CURE Media Group® announces Jane Fonda as keynote speaker for the 2023 MPN Heroes® recognition progr...

GlobeNewswire 02/11/2023 Merus Announces Financial Results for the Third Quarter 2023 and Provides Business Update

GlobeNewswire 23/10/2023 Elevar Therapeutics Names Brian Cunningham Vice President of Sales and Kenneth Rankin Vice President...

GlobeNewswire 12/10/2023 Global CAR T-cell Therapy Market Projected to Reach $83 Billion by 2032

GlobeNewswire 27/09/2023 Arcutis Appoints L. Todd Edwards as Chief Commercial Officer

TeleTrader 18/09/2023 Wall Street opens mostly lower, Fed anticipation builds up

GlobeNewswire 28/08/2023 Medicenna Announces the Appointment of Jeff Caravella as Chief Financial Officer

TeleTrader 07/02/2023 Wall Street back to losses, Dow slides 200 points

TeleTrader 07/02/2023 US markets lower amid economic data, Fed's Powell

GlobeNewswire 23/03/2022 RECELL® System Vitiligo Clinical Trial Protocol to be Presented at the Global Vitiligo Foundation An...

GlobeNewswire 14/03/2022 STRATA Skin Sciences Names John Bagdasarian as Vice President of Professional Relations

GlobeNewswire 01/03/2022 Actuate Therapeutics Announces First Patient Enrolled in Phase 2 Clinical Trial of Elraglusib Plus R...

GlobeNewswire 28/02/2022 Merus Announces Financial Results for the Fourth Quarter and Full Year 2021 and Provides Business Up...

GlobeNewswire 24/02/2022 MacroGenics Provides Update on Corporate Progress and 2021 Financial Results

INCYTE DL-,001/ US45337C1027 /

If you wish to receive reply to your feedback, please provide your email address.